ArticlePharmaceutics2021

Long-Term Oral Treatment with Non-Hypoglycemic Dose of Glibenclamide Reduces Diabetic Retinopathy Damage in the Goto-KakizakiRat Model.

Marianne Berdugo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.